By deepening the exploration of the TCR/BCR immune repertoires, the process of the occurrence and development of immune complexes in the process of tumor progression from benign to malignant has become clearer, and this change reveals important changes in the immune response, which is conducive to the understanding of tumor deterioration at the immune level. Here, BCR is linked to neoplasm.